BATTAGLIA, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 270
AS - Asia 217
EU - Europa 150
SA - Sud America 10
AF - Africa 2
OC - Oceania 2
Totale 651
Nazione #
US - Stati Uniti d'America 266
CN - Cina 136
IE - Irlanda 49
SG - Singapore 44
HK - Hong Kong 24
UA - Ucraina 23
RU - Federazione Russa 20
FI - Finlandia 18
DE - Germania 12
GB - Regno Unito 9
BR - Brasile 6
SE - Svezia 6
VN - Vietnam 6
BE - Belgio 5
AR - Argentina 3
AU - Australia 2
CH - Svizzera 2
FR - Francia 2
IN - India 2
MX - Messico 2
PL - Polonia 2
BD - Bangladesh 1
CA - Canada 1
DO - Repubblica Dominicana 1
ID - Indonesia 1
IL - Israele 1
IT - Italia 1
KW - Kuwait 1
MA - Marocco 1
NG - Nigeria 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
Totale 651
Città #
Dublin 49
Chandler 43
Jacksonville 36
Beijing 30
Ashburn 25
Hong Kong 24
Singapore 24
Ann Arbor 20
Nanjing 19
Dallas 14
Nanchang 14
Boardman 12
Jiaxing 9
Shenyang 9
Changsha 7
Lawrence 7
Medford 7
Princeton 7
Shanghai 7
Hangzhou 6
Hebei 6
Tianjin 6
Brussels 5
Buffalo 4
Helsinki 4
New York 4
Ho Chi Minh City 3
Moscow 3
Redondo Beach 3
Washington 3
Wilmington 3
Fairfield 2
London 2
Los Angeles 2
Norwalk 2
Warsaw 2
Zurich 2
Atlanta 1
Belgrade 1
Belo Horizonte 1
Berazategui 1
Brisbane 1
Campos Novos 1
Casablanca 1
Caseros 1
Chennai 1
Chicago 1
Clifton 1
Columbus 1
Córdoba 1
Denpasar 1
El Paso 1
Feira de Santana 1
Fort Worth 1
Guangzhou 1
Haifa 1
Hanoi 1
Helena 1
Huzhou 1
Jacundá 1
Jinan 1
Jurong 1
Kunming 1
Kuwait City 1
Lagos 1
Lahore 1
Langfang 1
Las Vegas 1
Lima 1
Lincolnton 1
Maddingley 1
Mariana 1
Matamoros 1
Montpellier 1
Ningbo 1
Oklahoma City 1
Philadelphia 1
San Jose 1
Santa Clara 1
Santiago de los Caballeros 1
Sri Ganganagar 1
Stockholm 1
Summerville 1
The Dalles 1
Topeka 1
Toronto 1
Vinh 1
Volta Redonda 1
Woodbridge 1
Yuncheng 1
Yên Bái 1
Totale 479
Nome #
MmpL3 is the cellular target of the antitubercular drug BM212. 112
Isolation and characterization of M. tuberculosis and M. bovis BCG mutants resistant to new antitubercular pyrrole derivatives. 105
The MmpL3 protein is responsible for resistance to BM212, a lead antitubercular drug. 99
Characterizing the MmpL3 protein, a novel target for new antitubercular agents. 82
The new antitubercular target MmpL3: insight protein expression trials. 72
Elucidating the organization of mmpL3 gene locus 72
Studies on the antitubercular drug target MmpL3 and its gene locus 68
The Cost of Imagined Actions in a Reward-Valuation Task 46
Totale 656
Categoria #
all - tutte 2.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 4 1 10 0 8 5 0
2021/202238 1 1 1 1 1 1 1 2 2 5 5 17
2022/2023135 10 9 5 6 14 10 0 12 58 4 4 3
2023/202450 2 7 4 6 7 14 2 4 0 2 1 1
2024/2025105 4 8 4 4 3 9 2 2 29 3 15 22
2025/2026123 32 9 22 16 41 3 0 0 0 0 0 0
Totale 656